Goldman Sachs Initiates Coverage on Jazz Pharmaceuticals plc – Ordinary Shares to Buy

Goldman Sachs Initiates Coverage on Jazz Pharmaceuticals plc – Ordinary Shares(NASDAQ:JAZZ). The shares have been rated Buy. The rating by Goldman Sachs was issued on Jun 6, 2016.

In a different note, On Jun 2, 2016, SunTrust Robinson Humphrey said it Maintains its rating on Jazz Pharmaceuticals plc – Ordinary Shares. In the research note, the firm Raises the price-target to $200.00 per share. The shares have been rated ‘Buy’ by the firm. On May 11, 2016, Mizuho Securities said it Upgrades its rating on Jazz Pharmaceuticals plc – Ordinary Shares. The shares have been rated ‘Buy’ by the firm. On Apr 25, 2016, SunTrust Robinson Humphrey said it Upgrades its rating on Jazz Pharmaceuticals plc – Ordinary Shares. In the research note, the firm Raises the price-target to $164.00 per share. The shares have been rated ‘Buy’ by the firm.

Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ) shares turned negative on Fridays trading session with the shares closing down -5.26 points or -3.37% at a volume of 5,49,926. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $154.71. The peak price level was also seen at $154.71 while the days lowest was $149.73. Finally the shares closed at $150.76. The 52-week high of the shares is $194.73 while the 52-week low is $108.5. According to the latest information available, the market cap of the company is $9,109 M.

Jazz Pharmaceuticals plc – Ordinary Shares(JAZZ) last announced its earnings results on May 10, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $336.01M. Analysts had an estimated revenue of $342.95M. Earnings per share were $2.26. Analysts had estimated an EPS of $2.35.

Several Insider Transactions has been reported to the SEC. On May 26, 2016, Seamus Mulligan (director) sold 27,968 shares at $150.13 per share price.Also, On May 17, 2016, Michael Patrick Miller (SVP, US Commercial) sold 100 shares at $145.20 per share price.On May 17, 2016, Heather Ann Mcsharry (director) sold 697 shares at $145.20 per share price, according to the Form-4 filing with the securities and exchange commission.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *